Video: Researchers aim to personalize breast cancer treatments

January 28, 2014 by Miles O'brien

With support from the National Science Foundation (NSF), bioengineer Karen Burg and her colleagues at Clemson University are developing and demonstrating a new, integrative means of studying the complex behavior of cancer cells in breast tissue. Their research may one day change the way doctors treat the disease.

"This work contributes to the basic understanding of how cells function and communicate with the environment in a three dimensional (3-D) tissue structure which is a challenging and unsolved problem," says Friedrich Srienc, a program director in the NSF's Directorate for Engineering, which funded the research.

The researchers are building scaffolds that mimic the 3-D structure of . They use a machine called a biofabricator to deposit at strategic locations inside the 3-D structures, just like tumors in human flesh. These structures are high-fidelity test systems. Burg and her team can culture cancer cells in them, experimenting to see which treatments are the most effective, with the ultimate goal of personalizing a treatment or a vaccine for individual patients.

The video will load shortly

Explore further: Helping the body regrow nerves: New strategy for restoring nerve function

Related Stories

Long-lived breast stem cells could retain cancer legacy

January 26, 2014

Researchers from Melbourne's Walter and Eliza Hall Institute have discovered that breast stem cells and their 'daughters' have a much longer lifespan than previously thought, and are active in puberty and throughout life.

First step of metastasis halted in mice with breast cancer

December 12, 2013

Cell biologists at Johns Hopkins have identified a unique class of breast cancer cells that lead the process of invasion into surrounding tissues. Because invasion is the first step in the deadly process of cancer metastasis, ...

Recommended for you

Double whammy for triple negative breast cancer

December 5, 2016

A promising new combination therapy for a particularly aggressive form of breast cancer has been identified by Weizmann Institute scientists, as was recently reported in Cancer Research. The potential dual-acting therapeutic ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.